Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
Potenza
M N
MN
Wasylink
S
S
Longhurst
J G
JG
Epperson
C N
CN
McDougle
C J
CJ
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D019233:Retreatment; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D017211:Treatment Failure
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D005473:Fluoxetine; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors